28 Long-term analysis of high-risk primary breast cancer patients enrolled in prospective trials of high-dose chemotherapy (HDC) and autologous hematopoietic progenitor cell transplant (AHPCT)
Year: 2003
Type: article
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $3,650
OpenAlex ID: W2006014710
